相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An update on the role of glutamate in the pathophysiology of depression
N. D. Mitchell et al.
ACTA PSYCHIATRICA SCANDINAVICA (2010)
Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder
Andrea J. Levinson et al.
BIOLOGICAL PSYCHIATRY (2010)
Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations
Andrea G. Ludolph et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Relevance of Norepinephrine-Dopamine Interactions in the Treatment of Major Depressive Disorder
Mostafa El Mansari et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Genetics of HPA-axis, depression and suicidality
D. Wasserman et al.
EUROPEAN PSYCHIATRY (2010)
Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy
Bernardo Dell'Osso et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Debbie G. A. Janssen et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Rethinking depression and the actions of antidepressants: Uncovering the links between the neural and behavioral elements
Martin M. Katz et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
Trisha Suppes et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Paraventricular Hypothalamic Nucleus: Axonal Projections to the Brainstem
Joel C. Geerling et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2010)
Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study
J. Segui et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
Karen Hewett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons
Noam S. Katz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies
Jennifer M. Loftis et al.
NEUROBIOLOGY OF DISEASE (2010)
Serotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose Antidepressants
Annette Beatrix Bruehl et al.
NEUROPSYCHOPHARMACOLOGY (2010)
The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment
Annamaria Cattaneo et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Desvenlafaxine Succinate: A Newer Antidepressant for the Treatment of Depression and Somatic Symptoms
Ho-Jun Seo et al.
POSTGRADUATE MEDICINE (2010)
Quetiapine XR: Current status for the treatment of major depressive disorder
Chi-Un Pae et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses
Luisella Bocchio-Chiavetto et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Incidence and onset of delayed seizures after overdoses of extended-release bupropion
Paul Starr et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2009)
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression
Rudolf Uher et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters
Jacob Andersen et al.
CHEMICAL COMMUNICATIONS (2009)
Efficacy of Reboxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Boys With Intolerance to M ethylphenidate: An Open-Label, 8-Week, Methylphenidate-Controlled Trial
Iris Cohen-Yavin et al.
CLINICAL NEUROPHARMACOLOGY (2009)
Desvenlafaxine: A New Serotonin-Norepinephrine Reuptake Inhibitor for the Treatment of Adults With Major Depressive Disorder
Richard Perry et al.
CLINICAL THERAPEUTICS (2009)
Desvenlafaxine 50 and 100 mg/d in the Treatment of Major Depressive Disorder: An 8-Week, Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial and a Post Hoc Pooled Analysis of Three Studies
Karen A. Tourian et al.
CLINICAL THERAPEUTICS (2009)
Atypical Depression A Comprehensive Review
Chi-Un Pae et al.
CNS DRUGS (2009)
Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
Grazia Dell'Agnello et al.
CNS DRUGS (2009)
Mirtazapine A Review of its Use in Major Depression and Other Psychiatric Disorders
Katherine F. Croon et al.
CNS DRUGS (2009)
Escitalopram Versus SNRI Antidepressants in the Acute Treatment of Major Depressive Disorder: Integrative Analysis of Four Double-Blind, Randomized Clinical Trials
Susan G. Kornstein et al.
CNS SPECTRUMS (2009)
Escitalopram in the treatment of major depressive disorder: A meta-analysis
Sidney H. Kennedy et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression
Michael Bauer et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: A pooled analysis
Edda Pjrek et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani et al.
LANCET (2009)
STIMULATION OF α1-ADRENOCEPTORS REDUCES GLUTAMATERGIC SYNAPTIC INPUT FROM PRIMARY AFFERENTS THROUGH GABAA RECEPTORS AND T-TYPE Ca2+ CHANNELS
W. -X. Yuan et al.
NEUROSCIENCE (2009)
Dual- and Triple-Acting Agents for Treating Core and Co-morbid Symptoms of Major Depression: Novel Concepts, New Drugs
Mark J. Millan
NEUROTHERAPEUTICS (2009)
Tobacco dependence and withdrawal: Science base, challenges and opportunities for pharmacotherapy
Jack E. Henningfield et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Venlafaxine-induced psychotic symptoms
AT Safeekh et al.
Indian Journal of Psychiatry (2009)
Treatment of SSRI-resistant depression: A meta-analysis comparing within-versus across-class switches
George I. Papakostas et al.
BIOLOGICAL PSYCHIATRY (2008)
Triple Reuptake Inhibitors: The Next Generation of Antidepressants
David M. Marks et al.
CURRENT NEUROPHARMACOLOGY (2008)
Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence
Jayesh Kamath et al.
Expert Review of Neurotherapeutics (2008)
Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders
Helen R. Winter et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2008)
Antidepressant-Like Pharmacological Profile of a Novel Triple Reuptake Inhibitor, (1S, 2S)-3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)
Yanqi Liang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
G. I. Papakostas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: A pooled survival analysis of 7 double-blind, randomized clinical trials
George I. Papakostas et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression
Mark E. Bangs et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2007)
An evaluation of the cardiovascular safety profile of duloxetine - Findings from 42 placebo-controlled studies
Joachim Wernicke et al.
DRUG SAFETY (2007)
Emerging treatments for depression
Paul E. Holtzheimer et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
A double-blind comparison between bupropion XL and venlafaxine XR - Sexual functioning, antidepressant efficacy, and tolerability
Michael E. Thase et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Bupropion extended release compared with escitalopram: Effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies
Anita H. Clayton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Use of bupropion in combination with serotonin reuptake inhibitors
S Zisook et al.
BIOLOGICAL PSYCHIATRY (2006)
Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: Update on new stimulant preparations, atomoxetine, and novel treatments
JB Prince
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2006)
Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain
HV Krell et al.
PSYCHOSOMATICS (2005)
Analytical method development and validation of mianserin hydrochloride and its metabolite in human plasma by LC-MS
B Chauhan et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man
EA Young et al.
PSYCHONEUROENDOCRINOLOGY (2005)
Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: A meta-analysis of original data from 7 randomized controlled trials
ME Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Duloxetine hydrochloride: A new dual-acting medication for the treatment of major depressive disorder
ME Hunziker et al.
CLINICAL THERAPEUTICS (2005)
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder
TE Wilens et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder
J Barton
ARCHIVES OF DISEASE IN CHILDHOOD (2005)
Clinical pharmacokinetics of atomoxetine
JM Sauer et al.
CLINICAL PHARMACOKINETICS (2005)
Social anxiety disorder - Current treatment recommendations
JE Muller et al.
CNS DRUGS (2005)
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression
MM Katz et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders
DA Morilak et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man
U Breyer-Pfaff
DRUG METABOLISM REVIEWS (2004)
Noradrenaline in mood and anxiety disorders: basic and clinical studies
N Brunello et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane
N Roz et al.
LIFE SCIENCES (2003)
Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression - Merged analysis of nortriptyline trials
M Kimura et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2003)
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression
N Brunello et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2002)
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
PW Gold et al.
MOLECULAR PSYCHIATRY (2002)
Venlafaxine extended-release - A review of its use in the management of major depression
K Wellington et al.
CNS DRUGS (2001)
Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression
JC Fleishaker
CLINICAL PHARMACOKINETICS (2000)
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression
JM Kent
LANCET (2000)
分享论文
